JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602919200 on August 25, 2006

J. Biol. Chem., Vol. 281, Issue 42, 31562-31571, October 20, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/42/31562    most recent
M602919200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandan, E.
Right arrow Articles by Marzolo, M.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandan, E.
Right arrow Articles by Marzolo, M.-P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Low Density Lipoprotein Receptor-related Protein Functions as an Endocytic Receptor for Decorin*

Enrique Brandan1, Claudio Retamal, Claudio Cabello-Verrugio2, and María-Paz Marzolo3

From the Centro de Regulación Celular y Patología "Joaquín V. Luco," CRCP, Departamento de Biología Celular y Molecular, MIFAB, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile

Decorin is a small leucine-rich proteoglycan that modulates the activity of transforming growth factor type beta and other growth factors and thereby influences the processes of proliferation and differentiation in a wide array of physiological and pathological reactions. Hence, understanding the regulatory mechanisms of decorin activity has broad implications. Here we report that the extracellular levels of decorin are controlled by receptor-mediated catabolism, involving the low density lipoprotein receptor family member, low density lipoprotein receptor-related protein (LRP). We show that decorin is endocytosed and degraded by C2C12 myoblast cells and that both processes are blocked by suppressing LRP expression using short interfering RNA. The same occurs with CHO cells, but not with CHO cells genetically deficient in LRP. Finally, we show that LRP-null CHO cells, transfected to express mini-LRP polypeptides containing either the second or fourth LRP ligand-binding domains, carry out decorin endocytosis and lysosomal degradation. These findings point to LRP-mediated catabolism as a new control pathway for the biological activities of decorin, specifically for its ability to influence extracellular matrix signaling.


Received for publication, March 28, 2006 , and in revised form, July 5, 2006.

* This work was supported in part FONDAP-Biomedicine Grants 13980001, MDA 3790, and FONDECYT 1020726. The Millennium Institute for Fundamental and Applied Biology is financed in part by the Ministerio de Planificación y Cooperación (Chile). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by an International Research Scholar grant from the Howard Hughes Medical Institute.

2 Supported by DIPUC and CONICYT Fellowship AT-24050108.

3 To whom correspondence should be addressed. Tel.: 56-2-6862112; Fax: 56-2-2229995; E-mail: mmarzolo{at}bio.puc.cl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
X. Li, A. Pennisi, and S. Yaccoby
Role of decorin in the antimyeloma effects of osteoblasts
Blood, July 1, 2008; 112(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Cabello-Verrugio and E. Brandan
A Novel Modulatory Mechanism of Transforming Growth Factor-beta Signaling through Decorin and LRP-1
J. Biol. Chem., June 29, 2007; 282(26): 18842 - 18850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.